Relief Therapeutics Holding AG
RLFTD · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 39.5% | -0.8% | 83.1% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 69.4% | 68.2% | 79.4% | -258.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -197% | -1,790.8% | -806.2% | -984.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -203.4% | -1,627.4% | -835.2% | -1,045% |
| EPS Diluted | -1.36 | -8.35 | -4.8 | -3.86 |
| % Growth | 83.7% | -74% | -24.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |